ProJenX and Unlearn partnered to implement genAI technology for a Phase I trial of prosetin for amyotrophic lateral sclerosis ...
The partnership will employ the ALS-Digital Twin Generator of Unlearn to enhance the trial's evaluation process.
Spinogenix, the company behind the once-a-day pill that restored lost nerve cell connections in people with amyotrophic ...
A group of eight molecules in the blood can be used as a biomarker to distinguish ALS from other neurodegenerative conditions ...
3d
About Rozebalamin (generic name: mecobalamin, development code: E0302) ...
Schlieren, Zurich/Switzerland, September 24, 2024 - Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived antibodies, today announced that it has ...
La Esperanza plans to open a new location in the Ivy at Berlin Place in the next few months amidst rapid growth on the south ...
Direct-to-participant study to reach 150 people living with ALS, with 2 participants already enrolled.
Inquirer on MSN9d
Brain implant lets man with amyotrophic lateral sclerosis control Amazon's Alexa with his thoughtsThe patient, who is living with amyotrophic lateral sclerosis (ALS), was able to make video calls, play music, stream shows, ...
Mayo Clinic researchers have just been awarded a new federal grant to start an investigation of an experimental drug on ...
A New Bedford man, Joseph Smith, admitted to stealing over $450,000 in disability benefits from a veteran with ALS and ...
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback